Cargando…

Neuronal response in Alzheimer’s and Parkinson’s disease: the effect of toxic proteins on intracellular pathways

Accumulation of protein aggregates is the leading cause of cellular dysfunction in neurodegenerative disorders. Alzheimer’s disease (AD), Parkinson’s disease (PD), Huntington’s disease, Prion disease and motor disorders such as amyotrophic lateral sclerosis, present with a similar pattern of progres...

Descripción completa

Detalles Bibliográficos
Autores principales:	Majd, Shohreh, Power, John H., Grantham, Hugh J. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4619058/ https://www.ncbi.nlm.nih.gov/pubmed/26499115 http://dx.doi.org/10.1186/s12868-015-0211-1

Ejemplares similares

Early glycogen synthase kinase‐3β and protein phosphatase 2A independent tau dephosphorylation during global brain ischaemia and reperfusion following cardiac arrest and the role of the adenosine monophosphate kinase pathway
por: Majd, Shohreh, et al.
Publicado: (2016)

Alzheimer’s Disease and Cancer: When Two Monsters Cannot Be Together
por: Majd, Shohreh, et al.
Publicado: (2019)

A comparison of LKB1/AMPK/mTOR metabolic axis response to global ischaemia in brain, heart, liver and kidney in a rat model of cardiac arrest
por: Majd, Shohreh, et al.
Publicado: (2018)

The impact of tau hyperphosphorylation at Ser(262) on memory and learning after global brain ischaemia in a rat model of reversible cardiac arrest
por: Majd, Shohreh, et al.
Publicado: (2016)

Dysregulation of Neuronal Iron Homeostasis as an Alternative Unifying Effect of Mutations Causing Familial Alzheimer’s Disease
por: Lumsden, Amanda L., et al.
Publicado: (2018)

Amyloid Beta Oligomers Target to Extracellular and Intracellular Neuronal Synaptic Proteins in Alzheimer's Disease
por: Ding, Yu, et al.
Publicado: (2019)

Unfolded Protein Response and Macroautophagy in Alzheimer’s, Parkinson’s and Prion Diseases
por: Milisav, Irina, et al.
Publicado: (2015)

Antioxidants inhibit neuronal toxicity in Parkinson's disease‐linked LRRK2
por: Angeles, Dario C., et al.
Publicado: (2016)

Loss of Drosha underlies dopaminergic neuron toxicity in models of Parkinson’s disease
por: Wang, Ronglin, et al.
Publicado: (2018)

Contribution of autofluorescence from intracellular proteins in multiphoton fluorescence lifetime imaging
por: Malak, Monika, et al.
Publicado: (2022)

Protein Traffic Is an Intracellular Target in Alcohol Toxicity
por: Esteban-Pretel, Guillermo, et al.
Publicado: (2011)

Intracellular Accumulation of Amyloid-Beta – A Predictor for Synaptic Dysfunction and Neuron Loss in Alzheimer's Disease
por: Bayer, Thomas A., et al.
Publicado: (2010)

Intracellular calcium signalling in Alzheimer’s disease
por: Hermes, Marina, et al.
Publicado: (2010)

Intracellular Calcium Dysregulation by the Alzheimer’s Disease-Linked Protein Presenilin 2
por: Galla, Luisa, et al.
Publicado: (2020)

Common microRNA regulated pathways in Alzheimer’s and Parkinson’s disease
por: Awuson-David, Betina, et al.
Publicado: (2023)

Intracellular crowding by age-dependent neuromelanin accumulation disrupts neuronal proteostasis and triggers Parkinson disease pathology
por: Vila, Miquel, et al.
Publicado: (2019)

Age‐ and disease‐specific changes of the kynurenine pathway in Parkinson’s and Alzheimer’s disease
por: Sorgdrager, Freek J. H., et al.
Publicado: (2019)

Intracellular and Intercellular Mitochondrial Dynamics in Parkinson’s Disease
por: Valdinocci, Dario, et al.
Publicado: (2019)

Parkinson’s disease risk genes act in glia to control neuronal α-synuclein toxicity
por: Olsen, Abby L, et al.
Publicado: (2021)

Endo-lysosomal proteins and ubiquitin CSF concentrations in Alzheimer’s and Parkinson’s disease
por: Sjödin, Simon, et al.
Publicado: (2019)

Intracellular Calcium Dysregulation: Implications for Alzheimer's Disease
por: Magi, Simona, et al.
Publicado: (2016)

Lessons on Differential Neuronal-Death-Vulnerability from Familial Cases of Parkinson’s and Alzheimer’s Diseases
por: Franco, Rafael, et al.
Publicado: (2019)

IGF2 prevents dopaminergic neuronal loss and decreases intracellular alpha-synuclein accumulation in Parkinson’s disease models
por: Arcos, Javiera, et al.
Publicado: (2023)

Impaired intracellular trafficking defines early Parkinson's disease
por: Hunn, Benjamin H.M., et al.
Publicado: (2015)

Polymodal Responses in C. elegans Phasmid Neurons Rely on Multiple Intracellular and Intercellular Signaling Pathways
por: Zou, Wenjuan, et al.
Publicado: (2017)

Loss of NEDD4 contributes to RTP801 elevation and neuron toxicity: implications for Parkinson's disease
por: Canal, Mercè, et al.
Publicado: (2016)

Mitochondrial Toxicant-Induced Neuronal Apoptosis in Parkinson’s Disease: What We Know so Far
por: Sivagurunathan, Narmadhaa, et al.
Publicado: (2023)

Redox regulation of mitochondrial fission, protein misfolding, synaptic damage, and neuronal cell death: potential implications for Alzheimer’s and Parkinson’s diseases
por: Nakamura, Tomohiro, et al.
Publicado: (2010)

Neurodegeneration in Alzheimer Disease: Role of Amyloid Precursor Protein and Presenilin 1 Intracellular Signaling
por: Nizzari, Mario, et al.
Publicado: (2012)

Intracellular Trafficking Mechanisms of Synaptic Dysfunction in Alzheimer’s Disease
por: Perdigão, Catarina, et al.
Publicado: (2020)

The intracellular milieu of Parkinson’s disease patient brain cells modulates alpha-synuclein protein aggregation
por: Gustavsson, Nadja, et al.
Publicado: (2021)

LRP10 interacts with SORL1 in the intracellular vesicle trafficking pathway in non-neuronal brain cells and localises to Lewy bodies in Parkinson’s disease and dementia with Lewy bodies
por: Grochowska, Martyna M., et al.
Publicado: (2021)

Gene-toxicant link to Parkinson's disease.
Publicado: (1999)

Parkinson's Disease: Is It a Toxic Syndrome?
por: Gad ELhak, Seham A., et al.
Publicado: (2010)

GTPase Activity and Neuronal Toxicity of Parkinson's Disease–Associated LRRK2 Is Regulated by ArfGAP1
por: Stafa, Klodjan, et al.
Publicado: (2012)

Parkinson's disease and dopaminergic neurons
Publicado: (2012)

Attenuated Postprandial GLP-1 Response in Parkinson’s Disease
por: Manfready, Richard A., et al.
Publicado: (2021)

Untangling the Tauopathy for Alzheimer’s disease and parkinsonism
por: Chang, Hui-Yun, et al.
Publicado: (2018)

Genetic networks in Parkinson’s and Alzheimer’s disease
por: Kelly, Jack, et al.
Publicado: (2020)

Alzheimer's and Parkinson's disease therapies in the clinic
por: Chopade, Puja, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fgb68ip1icd353kcc98j4ghmhj